GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients

Impact of Screening and Risk Factors for Local Recurrence and Survival After Conservative Surgery and Radiotherapy for Early Breast Cancer: Results From a Large Series With Long-Term Follow-Up

(2011) Ian H. Kunkler et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Clinical and biological significance of GSK-3β inactivation in breast cancer—an immunohistochemical study

(2010) Hanan Armanious et al.   HUMAN PATHOLOGY

Involvement of inactive GSK3β overexpression in tumorigenesis and progression of gastric carcinomas

(2010) Hua-chuan Zheng et al.   HUMAN PATHOLOGY

Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression

(2010) T Shimura et al.   ONCOGENE

Histological grading of invasive breast carcinoma – a simplification of existing methods in a large conservation series with long-term follow-up

(2009) Jeremy St J Thomas et al.   HISTOPATHOLOGY

Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy

(2008) Jia Luo   CANCER LETTERS

Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials

(2008) Brian R. Leyland-Jones et al.   JOURNAL OF CLINICAL ONCOLOGY